Derek Archila
Stock Analyst at Wells Fargo
(4.90)
# 259
Out of 4,531 analysts
909
Total ratings
57.4%
Success rate
22.2%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Rated: Buy | $155 | $106.60 | +45.40% | 61 | Jul 16, 2026 | |
| ANNX Annexon | Reiterated: Buy | $27 | $5.80 | +365.52% | 20 | Jul 15, 2026 | |
| QTTB Q32 Bio | Upgraded: Buy | $10 → $66 | $15.05 | +338.54% | 8 | Jul 14, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Hold | $25 | $23.12 | +8.13% | 24 | Jul 14, 2026 | |
| EXEL Exelixis | Maintained: Hold | $35 → $49 | $55.92 | -12.37% | 29 | Jul 13, 2026 | |
| XFOR X4 Pharmaceuticals | Initiated Coverage: Buy | $11 | $3.82 | +187.96% | 1 | Jul 10, 2026 | |
| TRAX First Tracks Biotherapeutics | Rated: Buy | $30 | $36.52 | -17.84% | 2 | Jul 10, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,180 → $1,291 | $860.55 | +50.02% | 77 | Jul 1, 2026 | |
| ALMS Alumis | Reiterated: Buy | $51 | $28.66 | +77.95% | 9 | Jul 1, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $54 | $35.35 | +52.76% | 20 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 → $31 | $18.03 | +71.94% | 18 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $33.40 | +43.71% | 12 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $24.56 | +18.08% | 17 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $101 | $117.25 | -13.86% | 39 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $326 | $261.00 | +24.90% | 44 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $10.73 | +132.99% | 12 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $8.01 | +87.27% | 25 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $40.26 | +11.77% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.5098 | +96.16% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $3.69 | +171.00% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $7.45 | +342.95% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $81.38 | +20.42% | 6 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.10 | +138.10% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $79 | $76.15 | +3.74% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $116 | $115.77 | +0.20% | 22 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $479 → $376 | $267.47 | +40.58% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $56 | $62.38 | -10.23% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $81 | $58.00 | +39.66% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 | $78.59 | -7.11% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $32.60 | +209.82% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $79.94 | -61.22% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $30 | $23.57 | +27.28% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $2 | $2.83 | -29.33% | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $24.19 | -42.12% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $5.11 | -2.15% | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $70.98 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.24 | $1.34 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $2.59 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.4707 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $8.26 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $40.23 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $30.01 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $553.48 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $14.70 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $13.94 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $37.08 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.70 → €16.57 | €3.94 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $4.62 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €288.71 → €290.45 | €746.00 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €91.58 → €96.00 | €26.04 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €13.30 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.61 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.44 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $12.77 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0111 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $10.72 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $32.03 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.966 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.29 | n/a | 1 | Oct 3, 2017 |
Rhythm Pharmaceuticals
Jul 16, 2026
Rated: Buy
Price Target: $155
Current: $106.60
Upside: +45.40%
Annexon
Jul 15, 2026
Reiterated: Buy
Price Target: $27
Current: $5.80
Upside: +365.52%
Q32 Bio
Jul 14, 2026
Upgraded: Buy
Price Target: $10 → $66
Current: $15.05
Upside: +338.54%
Nurix Therapeutics
Jul 14, 2026
Maintained: Hold
Price Target: $25
Current: $23.12
Upside: +8.13%
Exelixis
Jul 13, 2026
Maintained: Hold
Price Target: $35 → $49
Current: $55.92
Upside: -12.37%
X4 Pharmaceuticals
Jul 10, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.82
Upside: +187.96%
First Tracks Biotherapeutics
Jul 10, 2026
Rated: Buy
Price Target: $30
Current: $36.52
Upside: -17.84%
argenx SE
Jul 1, 2026
Maintained: Buy
Price Target: $1,180 → $1,291
Current: $860.55
Upside: +50.02%
Alumis
Jul 1, 2026
Reiterated: Buy
Price Target: $51
Current: $28.66
Upside: +77.95%
Celldex Therapeutics
Jun 30, 2026
Reiterated: Buy
Price Target: $54
Current: $35.35
Upside: +52.76%
Jun 30, 2026
Upgraded: Buy
Price Target: $20 → $31
Current: $18.03
Upside: +71.94%
Jun 29, 2026
Maintained: Buy
Price Target: $48
Current: $33.40
Upside: +43.71%
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $24.56
Upside: +18.08%
Jun 17, 2026
Maintained: Hold
Price Target: $101
Current: $117.25
Upside: -13.86%
Jun 17, 2026
Maintained: Buy
Price Target: $326
Current: $261.00
Upside: +24.90%
Jun 11, 2026
Rated: Buy
Price Target: $25
Current: $10.73
Upside: +132.99%
May 22, 2026
Maintained: Buy
Price Target: $15
Current: $8.01
Upside: +87.27%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $40.26
Upside: +11.77%
May 18, 2026
Rated: Hold
Price Target: $1
Current: $0.5098
Upside: +96.16%
May 13, 2026
Rated: Buy
Price Target: $10
Current: $3.69
Upside: +171.00%
May 12, 2026
Rated: Buy
Price Target: $33
Current: $7.45
Upside: +342.95%
May 9, 2026
Reiterated: Buy
Price Target: $98
Current: $81.38
Upside: +20.42%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.10
Upside: +138.10%
Mar 2, 2026
Maintained: Buy
Price Target: $78 → $79
Current: $76.15
Upside: +3.74%
Mar 2, 2026
Maintained: Buy
Price Target: $116
Current: $115.77
Upside: +0.20%
Jan 20, 2026
Maintained: Hold
Price Target: $479 → $376
Current: $267.47
Upside: +40.58%
Dec 16, 2025
Maintained: Sell
Price Target: $56
Current: $62.38
Upside: -10.23%
Dec 16, 2025
Maintained: Buy
Price Target: $51 → $81
Current: $58.00
Upside: +39.66%
Oct 17, 2025
Maintained: Buy
Price Target: $73
Current: $78.59
Upside: -7.11%
Oct 17, 2025
Maintained: Buy
Price Target: $101
Current: $32.60
Upside: +209.82%
Oct 17, 2025
Maintained: Buy
Price Target: $31
Current: $79.94
Upside: -61.22%
Aug 12, 2025
Maintained: Hold
Price Target: $40 → $30
Current: $23.57
Upside: +27.28%
Aug 8, 2025
Maintained: Hold
Price Target: $3 → $2
Current: $2.83
Upside: -29.33%
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $24.19
Upside: -42.12%
Aug 6, 2025
Maintained: Hold
Price Target: $6 → $5
Current: $5.11
Upside: -2.15%
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $70.98
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.24
Current: $1.34
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $2.59
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.4707
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $8.26
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $40.23
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $30.01
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $553.48
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $14.70
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $13.94
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $37.08
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €15.70 → €16.57
Current: €3.94
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $4.62
Upside: n/a
Mar 4, 2021
Maintained: Hold
Price Target: €288.71 → €290.45
Current: €746.00
Upside: n/a
Feb 19, 2021
Maintained: Hold
Price Target: €91.58 → €96.00
Current: €26.04
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €13.30
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.61
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $5.44
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $12.77
Upside: n/a
Mar 22, 2018
Maintained: Buy
Price Target: n/a
Current: $0.0111
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $10.72
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $32.03
Upside: n/a
Nov 9, 2017
Maintained: Hold
Price Target: n/a
Current: $0.966
Upside: n/a
Oct 3, 2017
Maintained: Hold
Price Target: n/a
Current: $17.29
Upside: n/a